Patent filed for collagen-based bioink to produce bioprinted organs and tissue

Written by Freya Leask

Collplant has filed a patent for a bioink, based on its proprietary rhCollagen product, for the bioprinting of 3D organs and tissue. After expanding its bioprinting division in May, Collplant (Israel) has filed a patent has been filed in the USA for a plant-based collagen bioink. Collplant seeks to protect its bioink, based on its rhCollagen, and form the basis for possible collaborations to produce 3D organs and tissue. Bioinks enable the printed of 3D scaffolds together with human cells or growth factors. Collplant’s bioink can be utilized in addition to other proteins or polymers that are compatible with the...

To view this content, please register now for access

It's completely free